Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Recent Developments in Cancer Systems Biology"
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (10 December 2020) | Viewed by 35499
Special Issue Editors
Interests: anti-cancer mechanisms of organo-selenium compounds; cancer biomarkers; chemoprevention; cancer therapy; dietary manipulations; inflammation; systems biology
Special Issues, Collections and Topics in MDPI journals
Special Issue in Biomedicines: Role of Trace Elements in Chemoprevention and Cancer Therapy 2.0
Special Issue in Biomedicines: Feature Reviews in Cancer Biomarkers
Interests: systems biology; bioinformatics; multi-omics data analysis; personalized medicine
Special Issue Information
Cancer is a complex disease that involves multifaceted mechanisms at transcriptional, translational, and biochemical levels. In addition, several molecules become important players in cancer progression and provide conducive environment for protein–protein interactions, metabolite cross-talk, and cell signaling. Studying such molecules may offer discovery of biomarkers, targetable clues for potentially repurposing drugs, as well as insights for developing predictive models of prognosis and improving cancer-free survival in patients. Systems biology has undoubtedly emerged as an integrative tool to achieve such advances. The Journal of Personalized Medicine is now opening a Special Issue that is fully devoted to ideas and research that build a strong foundation of Systems Biology in cancer research, with a call for papers involving basic, translational, and clinical research on this topic.
Dr. Raghu Sinha
Dr. Kazim Yalcin Arga
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- systems biology
- drug repurposing
- predictive models